Livzon Pharmaceutical Group Inc. (1513.HK)
HKD 25.9
(0.39%)
HKD 25.9
(0.39%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.95 Billion CNY | 2.32% |
| 2022 | 1.9 Billion CNY | 7.53% |
| 2021 | 1.77 Billion CNY | 3.54% |
| 2020 | 1.71 Billion CNY | 31.63% |
| 2019 | 1.3 Billion CNY | 20.39% |
| 2018 | 1.08 Billion CNY | -75.56% |
| 2017 | 4.42 Billion CNY | 464.63% |
| 2016 | 784.35 Million CNY | 25.97% |
| 2015 | 622.64 Million CNY | 20.67% |
| 2014 | 515.97 Million CNY | 5.84% |
| 2013 | 487.5 Million CNY | 10.38% |
| 2012 | 441.67 Million CNY | 22.9% |
| 2011 | 359.36 Million CNY | -14.06% |
| 2010 | 418.18 Million CNY | -13.16% |
| 2009 | 481.57 Million CNY | 824.81% |
| 2008 | 52.07 Million CNY | -89.76% |
| 2007 | 508.45 Million CNY | 265.4% |
| 2006 | 139.14 Million CNY | 28.97% |
| 2005 | 107.89 Million CNY | -13.03% |
| 2004 | 124.05 Million CNY | 34.55% |
| 2003 | 92.2 Million CNY | 48.85% |
| 2002 | 61.94 Million CNY | 22.92% |
| 2001 | 50.39 Million CNY | 385.67% |
| 2000 | 10.37 Million CNY | 529.81% |
| 1999 | 1.64 Million CNY | -95.97% |
| 1998 | 40.83 Million CNY | -5.47% |
| 1997 | 43.19 Million CNY | -46.96% |
| 1996 | 81.43 Million CNY | 1.6% |
| 1995 | 80.15 Million CNY | -20.72% |
| 1994 | 101.1 Million CNY | 0.0% |
| 1992 | 59.24 Million CNY | 2.52% |
| 1991 | 57.78 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 607.82 Million CNY | 72.63% |
| 2024 Q2 | 563.14 Million CNY | -7.35% |
| 2024 Q3 | 501.76 Million CNY | -10.9% |
| 2023 Q3 | 466.98 Million CNY | -15.5% |
| 2023 Q1 | 581.9 Million CNY | 44.54% |
| 2023 FY | 1.95 Billion CNY | 2.32% |
| 2023 Q2 | 552.66 Million CNY | -5.03% |
| 2023 Q4 | 352.09 Million CNY | -24.6% |
| 2022 Q1 | 553.29 Million CNY | 71.32% |
| 2022 Q3 | 489.25 Million CNY | 5.39% |
| 2022 Q4 | 402.59 Million CNY | -17.71% |
| 2022 Q2 | 464.25 Million CNY | -16.09% |
| 2022 FY | 1.9 Billion CNY | 7.53% |
| 2021 Q1 | 519.65 Million CNY | 77.14% |
| 2021 Q2 | 542.82 Million CNY | 4.46% |
| 2021 Q3 | 390.25 Million CNY | -28.11% |
| 2021 Q4 | 322.95 Million CNY | -17.25% |
| 2021 FY | 1.77 Billion CNY | 3.54% |
| 2020 Q3 | 416.8 Million CNY | -31.15% |
| 2020 FY | 1.71 Billion CNY | 31.63% |
| 2020 Q1 | 399.35 Million CNY | 51.83% |
| 2020 Q2 | 605.38 Million CNY | 51.59% |
| 2020 Q4 | 293.36 Million CNY | -29.62% |
| 2019 Q1 | 392.77 Million CNY | 176.47% |
| 2019 FY | 1.3 Billion CNY | 20.39% |
| 2019 Q2 | 346.17 Million CNY | -11.86% |
| 2019 Q3 | 300.88 Million CNY | -13.08% |
| 2019 Q4 | 263.03 Million CNY | -12.58% |
| 2018 Q1 | 347.36 Million CNY | 90.4% |
| 2018 Q4 | 142.07 Million CNY | -53.69% |
| 2018 Q3 | 306.75 Million CNY | 7.26% |
| 2018 FY | 1.08 Billion CNY | -75.56% |
| 2018 Q2 | 285.99 Million CNY | -17.67% |
| 2017 Q4 | 182.44 Million CNY | -95.12% |
| 2017 Q2 | 228.99 Million CNY | -16.73% |
| 2017 Q3 | 3.74 Billion CNY | 1534.23% |
| 2017 Q1 | 275.01 Million CNY | 62.17% |
| 2017 FY | 4.42 Billion CNY | 464.63% |
| 2016 Q4 | 169.57 Million CNY | -17.56% |
| 2016 FY | 784.35 Million CNY | 25.97% |
| 2016 Q3 | 205.71 Million CNY | 14.96% |
| 2016 Q2 | 178.94 Million CNY | -22.23% |
| 2016 Q1 | 230.11 Million CNY | 80.92% |
| 2015 Q2 | 158.19 Million CNY | -13.39% |
| 2015 Q4 | 127.18 Million CNY | -17.73% |
| 2015 Q3 | 154.6 Million CNY | -2.27% |
| 2015 Q1 | 182.65 Million CNY | 97.1% |
| 2015 FY | 622.64 Million CNY | 20.67% |
| 2014 FY | 515.97 Million CNY | 5.84% |
| 2014 Q4 | 92.66 Million CNY | -30.0% |
| 2014 Q3 | 132.37 Million CNY | -10.3% |
| 2014 Q2 | 147.58 Million CNY | 2.95% |
| 2014 Q1 | 143.35 Million CNY | 31.8% |
| 2013 Q4 | 108.76 Million CNY | -8.92% |
| 2013 Q1 | 146.73 Million CNY | 49.67% |
| 2013 Q3 | 119.42 Million CNY | 6.09% |
| 2013 FY | 487.5 Million CNY | 10.38% |
| 2013 Q2 | 112.57 Million CNY | -23.29% |
| 2012 Q3 | 114.92 Million CNY | 3.15% |
| 2012 Q1 | 117.29 Million CNY | 49.38% |
| 2012 FY | 441.67 Million CNY | 22.9% |
| 2012 Q2 | 111.41 Million CNY | -5.01% |
| 2012 Q4 | 98.04 Million CNY | -14.69% |
| 2011 FY | 359.36 Million CNY | -14.06% |
| 2011 Q1 | 125.81 Million CNY | 40.67% |
| 2011 Q2 | 95.04 Million CNY | -24.46% |
| 2011 Q3 | 59.99 Million CNY | -36.88% |
| 2011 Q4 | 78.51 Million CNY | 30.88% |
| 2010 Q3 | 87.26 Million CNY | -24.02% |
| 2010 FY | 418.18 Million CNY | -13.16% |
| 2010 Q1 | 126.62 Million CNY | -4.03% |
| 2010 Q2 | 114.85 Million CNY | -9.29% |
| 2010 Q4 | 89.43 Million CNY | 2.49% |
| 2009 Q4 | 131.93 Million CNY | 29.62% |
| 2009 FY | 481.57 Million CNY | 824.81% |
| 2009 Q3 | 101.78 Million CNY | -22.38% |
| 2009 Q2 | 131.13 Million CNY | 12.35% |
| 2009 Q1 | 116.72 Million CNY | 8371.92% |
| 2008 Q3 | -7.61 Million CNY | -180.14% |
| 2008 Q2 | 9.49 Million CNY | -81.59% |
| 2008 Q1 | 51.59 Million CNY | -11.75% |
| 2008 FY | 52.07 Million CNY | -89.76% |
| 2008 Q4 | -1.41 Million CNY | 81.46% |
| 2007 Q1 | 130.16 Million CNY | 141.33% |
| 2007 Q4 | 58.46 Million CNY | -73.13% |
| 2007 Q3 | 217.6 Million CNY | 112.9% |
| 2007 Q2 | 102.2 Million CNY | -21.48% |
| 2007 FY | 508.45 Million CNY | 265.4% |
| 2006 Q4 | 53.93 Million CNY | 125.17% |
| 2006 Q3 | 23.95 Million CNY | -24.88% |
| 2006 Q2 | 31.88 Million CNY | 8.55% |
| 2006 Q1 | 29.37 Million CNY | 8.29% |
| 2006 FY | 139.14 Million CNY | 28.97% |
| 2005 FY | 107.89 Million CNY | -13.03% |
| 2005 Q4 | 27.12 Million CNY | 132.82% |
| 2005 Q3 | 11.65 Million CNY | -68.4% |
| 2005 Q2 | 36.86 Million CNY | 14.31% |
| 2005 Q1 | 32.25 Million CNY | 25.27% |
| 2004 Q4 | 25.74 Million CNY | 30.31% |
| 2004 FY | 124.05 Million CNY | 34.55% |
| 2004 Q1 | 52.61 Million CNY | 38.23% |
| 2004 Q2 | 25.94 Million CNY | -50.69% |
| 2004 Q3 | 19.75 Million CNY | -23.84% |
| 2003 Q3 | 11.69 Million CNY | -40.2% |
| 2003 Q4 | 38.06 Million CNY | 225.56% |
| 2003 FY | 92.2 Million CNY | 48.85% |
| 2003 Q1 | 22.89 Million CNY | 437.81% |
| 2003 Q2 | 19.54 Million CNY | -14.62% |
| 2002 Q3 | 26.29 Million CNY | 24.11% |
| 2002 Q2 | 21.18 Million CNY | -0.23% |
| 2002 FY | 61.94 Million CNY | 22.92% |
| 2002 Q1 | 21.23 Million CNY | 0.0% |
| 2002 Q4 | -6.77 Million CNY | -125.78% |
| 2001 FY | 50.39 Million CNY | 385.67% |
| 2000 FY | 10.37 Million CNY | 529.81% |
| 1999 FY | 1.64 Million CNY | -95.97% |
| 1998 FY | 40.83 Million CNY | -5.47% |
| 1997 FY | 43.19 Million CNY | -46.96% |
| 1996 FY | 81.43 Million CNY | 1.6% |
| 1995 FY | 80.15 Million CNY | -20.72% |
| 1994 FY | 101.1 Million CNY | 0.0% |
| 1992 FY | 59.24 Million CNY | 2.52% |
| 1991 FY | 57.78 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 105.03 Million HKD | -1759.929% |
| Grand Pharmaceutical Group Limited | 1.87 Billion HKD | -3.918% |
| Extrawell Pharmaceutical Holdings Limited | -162.94 Million HKD | 1298.934% |
| Wai Yuen Tong Medicine Holdings Limited | -15.35 Million HKD | 12822.394% |
| Qianhai Health Holdings Limited | -52.7 Million HKD | 3806.766% |
| Lee's Pharmaceutical Holdings Limited | 16.69 Million HKD | -11599.909% |
| Essex Bio-Technology Limited | 275.25 Million HKD | -609.748% |
| Tongfang Kontafarma Holdings Limited | -28.84 Million HKD | 6873.397% |
| PuraPharm Corporation Limited | -106.08 Million HKD | 1941.66% |
| SSY Group Limited | 1.31 Billion HKD | -48.159% |
| JBM (Healthcare) Limited | 130.46 Million HKD | -1397.475% |
| Jacobson Pharma Corporation Limited | 266.96 Million HKD | -631.792% |
| China Resources Pharmaceutical Group Limited | 3.85 Billion HKD | 49.312% |